Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06110962

Detecting Heart Rate, Respiration, and Sleep With the Sleeptracker-AI Under-mattress Monitor

The objective of this study is to simultaneously acquire sleep and breathing data using the under-mattress Sleeptracker (The Sleeptracker-AI Monitor (Fullpower Technologies, California, USA) during routine PSGs in patients who attend the Woolcock Institute for undergoing investigation for possible obstructive sleep apnoea (OSA).

Recruiting

Interested in participating?

Request Info

Key information

Conditions

OSA

Age range

20 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Woolcock Institute of Medical Research

Macquarie Park, New South Wales, 2113, Australia

Location status: Recruiting

Location contact

Craig Phillips, PhD

PRINCIPAL_INVESTIGATOR

Grigori Kaplan, PhD

CONTACT

[email protected]

+61 98053232

About this study

The objective of this study is to simultaneously acquire sleep and breathing data using the under-mattress Sleeptracker (The Sleeptracker-AI Monitor (Fullpower Technologies, California, USA) during routine PSGs in patients who attend the Woolcock Institute for undergoing investigation for possible obstructive sleep apnoea (OSA). The de-identified Sleeptracker and PSG data will then be used by Fullpower Technologies to improve the accuracy of their current algorithm for detecting sleep and breathing disorders using the Sleeptracker device.

De-identified data recorded from the Sleeptracker device and PSG data from the Compumedics Grael system will be manually uploaded to a secure commercial server maintained by Fullpower Technologies.

Fullpower Technologies will use the de-identified data to refine their algorithms for detecting sleep and breathing disturbances.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 20-90 years old at time of assessment.
  • Attending the Woolcock Institute for an overnight sleep study for investigation of sleep apnoea.
  • Able to give informed consent.
  • Fluent in English.

Exclusion criteria

  • Unable to understand study procedure.
  • Unable to sign informed consent form.

Treatment and study plan

Sleeptracker-AI

Device

The Sleeptracker-AI Monitor (Fullpower Technologies, California, USA) is a commercially available, unobtrusive, and non-wearable home sleep monitoring device. It is either pre-installed in a mattress or can be purchased separately by consumers where it is placed under the mattress. The device uses piezo-electric sensors that register the forces exerted through the mattress by features such as the subject's motion, respiration, heartbeats, and snoring vibrations.

Primary outcomes

  1. Apnea Hypopnea Index

    Time frame: One night

    AHI (events per hour of sleep)

Secondary outcomes

  1. Total Sleep Time

    Time frame: One night

    Total Sleep Time (minutes)

  2. NREM Sleep Time

    Time frame: One night

    Non-REM sleep time (minutes)

  3. REM Sleep Time

    Time frame: One night

    REM sleep time (minutes)

Study contacts

Contact information is provided by the study sponsor or research team.

Camillah Hoyos, PhD

CONTACT

[email protected]

+61298053229

Craig L Phillips, PhD

CONTACT

[email protected]

+61298053017

Sponsors and collaborators

Lead sponsor

Woolcock Institute of Medical Research

Other

Collaborators

  • Fullpower Technologies, Inc.

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2028
First posted
Nov 1, 2023
Registry last updated
Mar 28, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.